CSI Market
Sign In | Register

Genomic Health Inc (GHDX) Annual Income Statement

Annual · GAAP · USD millions
Access GHDX quarterly income statements →
The income statement data below highlights shifts in Genomic Health Inc's operating performance over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2018)
2018 		(Dec 31 2017) (Dec 31 2016) (Dec 31 2015) (Dec 31 2014)
Revenues
Contracts Revenue0.00
Revenue From Contract With Customer Including Assessed Tax394.11
Total Revenue394.11
Costs & Expenses
Cost of Goods and Services Sold64.33
Gross Profit329.79
Selling, Administration, Marketing241.69
Research and Development Expense64.20
Other Operating Expense / -Income0.00
Total operating costs including COS370.22
Operating income / -loss23.90
Net Interest Expense / -Income0.00
Investment Income, Interest0.00
Other loss / -income-3.03
Total costs & expenses367.19
Income & Taxes
Income / -loss before income taxes26.92
Income taxes expenses / -benefit1.25
Income after income taxes25.68
Net income / -loss of other equity0.00
Income / -loss from continuing operations25.68
Net income / -loss25.68
Income / -loss to shareholder25.68
EBIT26.92
EBITD39.59
EBITDA39.72
Earnings Per Share
Basic EPS (excl. extra items)0.72
Basic Net EPS0.72
Basic shares outstanding (Mill. of Units)35.73
Diluted Net EPS0.68
Diluted average shares (Mill. of Units)37.56
4 historic quarters locked

Sign in to unlock the full Genomic Health Inc income statement history.

Sign In Create Free Account

About GHDX Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.